Medico Remedies Hits Upper Circuit Amid Strong Buying Pressure and Robust Trading Activity

Intraday Price Movement and Trading Range

On the trading day, Medico Remedies' share price touched an intraday high of ₹53.88, marking a near 9.98% gain from the previous close. The stock traded within a wide price band of ₹5.33, with the low price recorded at ₹48.55. The last traded price (LTP) stood at ₹53.82, closely aligning with the day's peak, underscoring sustained demand throughout the session.

Volume and Turnover Analysis

The total traded volume for the day reached approximately 52.76 lakh shares, generating a turnover of ₹2.78 crore. This volume reflects a substantial level of liquidity for a micro-cap stock, supported by a delivery volume of 75,680 shares on 22 Dec, which is 33.19% higher than the five-day average delivery volume. Such rising investor participation indicates growing confidence in the stock’s prospects.

Comparison with Sector and Market Benchmarks

Medico Remedies outperformed the Pharmaceuticals & Biotechnology sector by 10.26% on the day, while the sector itself recorded a marginal decline of 0.28%. The Sensex index showed a modest gain of 0.07%, highlighting the stock’s relative strength amid a broadly flat market environment. This divergence emphasises the stock’s appeal to investors seeking opportunities within the pharmaceutical micro-cap segment.

Technical Positioning and Moving Averages

The stock is trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests a positive momentum trend, which may attract further interest from traders and investors monitoring chart-based signals. The weighted average price indicates that a significant portion of volume was traded closer to the lower end of the day’s price range, signalling early accumulation before the price rally.

Upper Circuit Trigger and Regulatory Freeze

Medico Remedies reached its maximum permissible daily price movement limit, triggering an upper circuit at 10%. This regulatory mechanism is designed to curb excessive volatility by temporarily halting further price advances once the threshold is met. As a result, trading in the stock was subject to a freeze, preventing additional upward price movement for the remainder of the session. This freeze reflects the strong demand that could not be fully matched by available supply at prevailing prices.

Unfilled Demand and Market Sentiment

The upper circuit hit by Medico Remedies indicates a scenario where buy orders significantly outnumber sell orders, leading to unfilled demand. This imbalance often signals positive market sentiment and investor optimism regarding the company’s future prospects. Given the stock’s micro-cap status with a market capitalisation of approximately ₹447.12 crore, such price action can attract attention from both retail and institutional participants seeking growth opportunities in the Pharmaceuticals & Biotechnology sector.

Liquidity and Trade Size Considerations

Despite its micro-cap classification, Medico Remedies demonstrated sufficient liquidity to support trade sizes of around ₹0.01 crore, based on 2% of the five-day average traded value. This level of liquidity is crucial for investors aiming to enter or exit positions without causing significant price disruption. The stock’s ability to sustain high volumes and turnover on a day of strong price movement underscores its growing market presence.

Outlook and Investor Takeaways

Medico Remedies’ performance on 23 Dec 2025 highlights a notable episode of strong buying interest and technical strength. The stock’s outperformance relative to its sector and the broader market, combined with its position above key moving averages, suggests a positive momentum phase. However, the regulatory freeze imposed due to the upper circuit limit also indicates that supply constraints may temper immediate further gains.

Investors should consider the stock’s micro-cap nature and the inherent volatility associated with such companies. While the current price action reflects enthusiasm, it is prudent to monitor subsequent trading sessions for confirmation of sustained demand and volume support. The pharmaceutical sector’s evolving dynamics and Medico Remedies’ operational performance will remain key factors influencing future price movements.

Sector Context and Market Environment

The Pharmaceuticals & Biotechnology sector has experienced mixed performance in recent sessions, with many stocks facing pressure amid regulatory scrutiny and evolving market conditions. Medico Remedies’ distinct price action stands out against this backdrop, suggesting company-specific factors or renewed investor interest. The micro-cap segment often attracts speculative activity, and the current momentum may reflect expectations of upcoming developments or operational milestones.

Summary of Key Metrics

To summarise, Medico Remedies’ key trading metrics on 23 Dec 2025 include:

• Intraday high price: ₹53.88


• Price band range: ₹5.33


• Total traded volume: 52.76 lakh shares


• Turnover: ₹2.78 crore


• Delivery volume increase: 33.19% over 5-day average


• Market capitalisation: ₹447.12 crore (micro-cap)


• Outperformance vs sector: 10.26%


• Outperformance vs Sensex: 9.91% (sector down 0.28%, Sensex up 0.07%)

These figures illustrate a day of robust activity and strong investor interest, culminating in the stock reaching its upper circuit limit.

Investor Caution and Next Steps

While the upper circuit event is a positive indicator of demand, investors should remain cautious given the potential for volatility in micro-cap stocks. Monitoring volume trends, price consolidation, and sector developments will be essential in assessing the sustainability of this rally. Additionally, regulatory updates and company announcements should be closely followed to gauge any fundamental changes impacting Medico Remedies’ valuation.

Overall, the stock’s performance on this day marks a noteworthy moment in its trading history, reflecting a confluence of strong buying pressure, liquidity, and market interest within the Pharmaceuticals & Biotechnology sector.

Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →